Diabetes patients will be able to receive free online medication monitoring through an agreement made between Quintiles and the American Diabetes Association.

The world’s largest life science services company and association announced the agreement Wednesday.

Financial terms were not disclosed.

Through the partnership, members of the ADA can register for the service that will be provided by Quintiles’ Digital Patient Unit and its MediGuard website.

The service will include free safety checks to help identify any potential drug interactions and other risk factors. Related offerings regarding patient health also will be made available. 

“We are very pleased to offer this medication monitoring service to improve the lives of all people affected by diabetes,” said Vivian Fonseca, MD, president for medicine and science at the ADA. “This collaboration with Quintiles enables the Association to provide important safety information at no cost to our constituents”.

Registration data will be maintained by Quintiles.

“This relationship between Quintiles and the American Diabetes Association illustrates the manner in which associations help promote better health outcomes for their members or constituents,” said David Coman, who heads the Digital Patient Unit for Quintiles. “The very first pharma project undertaken by our founder [Dr. Dennis Gillings] involved a diabetes treatment, so it is fitting that we are innovating in this area once again on our 30-year anniversary.”

Quintiles took over operation of the MediGuard website earlier this year. 

[QUINTILES ARCHIVE: Check out a decade of Quintiles stories as reported in WRAL Tech Wire by clicking here.]